Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity
Stopped Axogen suspended market availability of the Avive® Soft Tissue Membrane effective June 1, 2021. This decision was not related to any safety concerns or product quality issues.
Conditions
- Acute Upper Extremity Trauma
Interventions
- OTHER: Minimally Processed Human Umbilical Cord Membrane
- OTHER: Standard Surgical Procedures
Sponsor
Axogen Corporation